Cutaneous recall phenomenon at the site of previous doxorubicin extravasation after second-line chemotherapy.
Valencak
Julia
J
Troch
Marlene
M
Raderer
Markus
M
D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects*; D004487:Edema / Q000139:chemically induced; D004890:Erythema / Q000139:chemically induced; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000150:complications*; D005260:Female; D005542:Forearm; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy; D008942:Mitoxantrone / Q000009:adverse effects; D010146:Pain / Q000139:chemically induced; D012867:Skin / Q000187:drug effects* / Q000473:pathology*
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; D008942:Mitoxantrone